-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

612. Acute Lymphoblastic Leukemia: Clinical Studies: Poster II

Acute Lymphoblastic Leukemia: Clinical Studies Program: Oral and Poster Abstracts
Type: Poster
Sunday, December 6, 2015: 6:00 PM-8:00 PM
Hall A, Level 2 (Orange County Convention Center)

Simona Soverini, PhD1, Caterina De Benedittis, PhD1*, Claudia Venturi, PhD2*, Cristina Papayannidis, MD, PhD3, Manuela Mancini, PhD1*, Katerina Machova Polakova4*, Domenico Russo, MD, PhD5, Paola Bresciani, MD6*, Alessandra Iurlo, MD, PhD7*, Elisabetta Abruzzese, MD8, Federica Sorà, MD, PhD9*, Michele Baccarani10, Michele Cavo, MD2*, Torsten Haferlach11 and Giovanni Martinelli, MD, PhD3

1"Seràgnoli" Institute of Hematology, Bologna University School of Medicine, Bologna, Italy
2Institute of Hematology, S.Orsola-Malpighi University Hospital, Bologna, Italy
3Bologna University School of Medicine, Bologna, Italy
4Institute of Hematology and Blood Transfusion, University of Prague, Prague, Czech Republic
5Chair of Hematology, Unit of Blood Diseases and Stem Cell Transplantation, University of Brescia, Brescia, Italy
6University of Modena, Bone Marrow Transplant Unit, Department of Oncology and Hematology, Modena, Italy
7Division of Hematology, IRCCS Maggiore Policlinico Hospital Foundation, Milano, Italy
8Hematology, S. Eugenio Hospital, Roma, Italy
9Università Cattolica del Sacro Cuore, Rome, Italy
10Institute of Hematology, University of Bologna, Bologna, Italy
11MLL Munich Leukemia Laboratory, Munich, Germany

Hassan B Alkhateeb, MD1, Tasha Lin, MD2, Moussab Damlaj, MD1, Aref Al-Kali, MD1, Naseema Gangat, MBBS1, William J Hogan, MBChB1, Michelle Elliott, MD1*, Grzegorz S. Nowakowski, MD1, Carrie Thompson, MD1, Thomas E. Witzig, MD1, Stephen M Ansell, M.D., Ph.D.1, Mark R Litzow, MD1 and Mrinal M Patnaik, MBBS1

1Division of Hematology, Mayo Clinic, Rochester, MN
2Department of Internal Medicine, Mayo Clinic, Rochester, MN

Eunice S. Wang, MD1, Gary J Schiller, MD2, Leonard T. Heffner, MD3, Wendy Stock, MD4, Arati V. Rao, MD5, Gail J. Roboz, MD6, Peter Westervelt, MD, PhD7, Matthew J. Wieduwilt, MD, PhD8, Jay Yang, MD9, Lucy Prasad10*, Karen Segarini10* and Stuart L. Goldberg, MD11

1Department of Medicine, Roswell Park Cancer Institute, Buffalo, NY
2University of California, Los Angeles, CA
3Department of Hematology and Medical Oncology, Emory University - Winship Cancer Institute, Atlanta, GA
4University of Chicago Medical Center, Chicago, IL
5Duke Cancer Institute, Duke University, Durham, NC
6Division of Hematology and Oncology, Department of Medicine, Weill Cornell Medical College, New York, NY
7Department of Medicine, Division of Oncology, Washington University School of Medicine, St. Louis, MO
8University of California, San Diego, La Jolla, CA
9Department of Oncology, Wayne State University and Karmanos Cancer Institute, Detroit, MI
10spectrum pharmaceuticals, irvine
11Division of Leukemia, John Theurer Cancer Center of Hackensack University Medical Center, Hackensack, NJ

Xavier Thomas, MD, PhD1, Yves Bertrand, MD, PhD2*, Andre Baruchel, MD, PhD3, Nicolas Blin, MD4*, Emmanuelle Tavernier, MD5*, Stephane Ducassou, MD6*, Norbert Vey7, Virginie Gandemer, MD, PhD8, Victoria Cacheux, MD9*, Francoise Mazingue, MD10, Emmanuel Raffoux11*, Genevieve Plat, MD12*, Jose Fernandes, MD13*, Maryline Poiree, MD14*, Luc Fornecker, MD15*, Jean-Louis Stephan, MD16*, Mathilde Hunault, MD, PhD17*, Anne Auvrignon, MD18*, Thibault Leguay, MD19*, Stephane Lepretre, MD20*, Alina Ferster, MD, PhD21, Isabelle Pellier, MD22*, Emmanuel Plouvier, MD23*, Claudine Schmitt24*, Cecile Bonin, Pharm D25*, Yann Godfrin, PhD25 and Iman El Hariry, MD, PhD25*

1Hematology Department, Hopital Edouard Herriot, Lyon, France
2Pediatric hematology, CHU Lyon, Lyon, France
3Pediatric Hematology, Hopital Saint Louis, Paris, France
4Department of Hematology, Nantes University Hospital, Nantes, France
5hematology, Institut de cancerologie de la Loire, Saint Priez en jarez, 42271, France
6Pediatric Hematology, CHU de Bordeaux,Hopital des Enfants-Hôpital Pellegrin, Bordeaux, France
7Hematology, Institut Paoli-Calmettes, Marseille, France
8Pediatric Hematology, Centre Hospitalier Universitaire de Rennes, Rennes, France
9Hematology Clermont Ferrand,, CHU Clermont Ferrand, Clermont Ferrand, France
10hematology, CHRU Lille, Lille, France
11Hematology Department, Saint Louis Hospital, Paris, France
12pediatric hematology, CHU Toulouse, Toulouse, France
13Centre Hospitalier Valenciennes Hematology, Valenciennes, France
14CHU Lenval Pediatric Hematology, Nice, France
15Oncology and Hematology, Hopital de Hautepierre, Strasbourg, France
16Hopital Nord - CHU Saint Etienne, Saint Priez en jarez, 42271, France
17Hematology Department, CHU, Angers, France
18Pediatric Hematology, AP-HP,GH-HUEP Trousseau Hospital, PARIS, France
19Department of Hematology, CHU, Bordeaux, Bordeaux,, France
20Hematology, CLCC H Becquerel, Rouen, France
21Dept. of Hémato-oncologie pédiatrique, Children's University Hospital Reine Fabiola, Brussels, Belgium
22CHU Angers, Angers Cedex, France
23pediatric hematology, CHRU Besançon, Besançon, France
24Pediatric Hematology, CHU de nancy, Nancy, France
25ERYTECH Pharma, Lyon, France

Rob S Sellar, MBChB, FRCPath1,2*, Clare Rowntree, PhD3*, Ajay J. Vora4, Caroline L Furness, MD5*, Nicholas Goulden, MD, PhD6, Chris Mitchell, FRCPCH7*, Anthony V. Moorman, PhD8 and Rachael Hough, MD, BMBS, FRCP, FRCPath1*

1Cancer Institute, University College London, London, United Kingdom
2Department of Haematology, University College London Hospitals, London, United Kingdom
3University Hospital of Wales, Cardiff, United Kingdom
4Dept. of Pediatric Hematology, The Children's Hospital, Sheffield, United Kingdom
5Haemato-Oncology, Royal Marsden NHS Foundation Trust, London, United Kingdom
6Department of Haematology, Great Ormond Street Hospital For Children, London, United Kingdom
7John Radcliffe Hospital, Oxford, United Kingdom
8Northern Institute for Cancer Research, Newcastle University, Newcastle upon Tyne, United Kingdom

Myriam Ruth Guitter, MD1*, Jorge Gabriel Rossi, PhD2*, Elisa Sajaroff, PhD3*, Carolina Carrara, PhD3*, Pizzi Silvia, MD4*, Raquel Staciuk, MD5*, Eduardo Lagomarsino, PhD1*, Natalia Millan, MD1*, Patricia Rubio, PhD1*, Cristina Noemi Alonso, PhD1*, Pedro Zubizarreta, MD1* and Maria Sara Felice, MD, PhD1*

1Hematology and Oncology, Hospital Nacional de Pediatria Prof. Dr. J. P. Garrahan, Buenos Aires, Argentina
2Immunology and Rheumatology, Hospital Nacional de Pediatría Prof. Dr. J. P. Garrahan, Buenos Aires, Argentina
3Immunology and Rheumatology, Hospital Nacional de Pediatria Prof. Dr. J. P. Garrahan, Buenos Aires, Argentina
4Stem Cell Transplantation Unit, Hospital Nacional de Pediatria Prof. Dr. J. P. Garrahan, Buenos Aires, Argentina
5Stem Cell Transplantation Unit, Hospital Nacional de Pediatria Prof. Dr. J. P. Garrahan, Buenos Aires, Argentina

Lidewij T Warris, MD1,2*, Marry M van den Heuvel-Eibrink, MD, PhD1,3, Femke K Aarsen, MSc PhD1*, Saskia MF Pluijm4*, Marc B Bierings, MD PhD5, Cor van den Bos, MD PhD6*, Christian M. Zwaan, MD, PhD1, Wim JE Tissing, MD, PhD7*, Margreet A Veening, MD8*, Rob Pieters, MD, PhD3,9 and Erica LT van den Akker, MD PhD2*

1Department of Pediatric Oncology, Erasmus MC-Sophia Children's Hospital, Rotterdam, Netherlands
2Department of Pediatric Endocrinology, Erasmus MC-Sophia Children's Hospital, Rotterdam, Netherlands
3Princess Máxima Centre for Pediatric Oncology, Utrecht, Netherlands
4Department of Paediatric Oncology/Hematology, Erasmus MC-Sophia’s Children’s Hospital, Rotterdam, Netherlands
5Department of Hematology and Immunology, Wilhelmina Children's Hospital, Utrecht, Netherlands
6Department of Pediatric Oncology, Academic Medical Center, Amsterdam, Netherlands
7Department of Paediatric Oncology, University Medical Center Groningen, Groningen, Netherlands
8Department of Pediatric Oncology, VU medical center, Amsterdam, Netherlands
9Department of Pediatric Oncology/Hematology, Erasmus MC - Sophia Children's Hospital, Rotterdam, Netherlands

Koji Sasaki, MD1, Susan O'Brien, MD2, Farhad Ravandi, MD2, Deborah A Thomas, MD2, Haim G Moore2*, Jorge E. Cortes, MD2, Naveen Pemmaraju, MD2, Musa Yilmaz, MD3*, Tapan Kadia, MD4, Rebecca Garris2*, Guillermo Garcia-Manero, MD2, Twilla Victoria Jeanis, RN2*, Jad Chahoud, MD5, Gautam Borthakur, MD2, William Wierda, MD, PhD4, Alessandra Ferrajoli, MD2, Hagop M. Kantarjian, MD2 and Elias Jabbour2

1Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX
2Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
3Department of Hematology & Oncology, Baylor College of Medicine, Houston, TX
4Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX
5University of Texas Hosuton Health Science Center, Houston, TX

Elena N. Parovichnikova, MD, PhD1*, Vera V. Troitskaya, MD, PhD1*, Andrey Sokolov2*, Galina Kliasova2*, Larisa A. Kuzmina, MD, PhD3*, Sergey Kravchenko, MD, PhD1*, Elena Gribanova2*, Segey Bondarenko4*, Olga Baranova5*, Tatyana Kaporskaya6*, Tatyana Ryltzova7*, Nina Minaeva8*, Tatiana Zinina9*, Olga Samoilova10*, Alfiya Nizamutdinova11*, Alexandra Klimovich12*, Elena Karyakina13*, Alexandra Eluferieva14*, Lyubov Gavrilova, MD,15*, Tatyana Konstantinova16*, Natalya Vopilina17*, Kamil Kaplanov18*, Valery A. Lapin19*, Alexander Pristupa20*, Tatyana Tikunova21*, Zalina Akhmerzaeva2*, Tatiana N. Obukhova, PhD1*, Mikhail Rusinov2*, Sergei M Kulikov, PhD1* and Valeri G. Savchenko, MD, PhD, Prof.1

1National Research Center for Hematology, Moscow, Russia
2National Research Center For Hematology, Moscow, Russia
3Department of BMT, National Research Center for Hematology, Moscow, Russia
4Raisa Gorbacheva Memorial Institute, Saint-Petersburg, Russia
5Nathional Research Center For Oncology, Moscow, Russia
6Irkutsk's Regional Hospital, Irkutsk, Russia
7Tula's Regional Hospital, Tula, Russia
8Kirov's Blood Transfusion Research Center, Kirov, Russia
9Surgut's Clinical Hospital, Surgut, Russia
10GBUZ NO NOKB Im N.a.Semashko, Nizhniy Novgorod, Russia
11Alexander Multisectoral Hospital, St. Petersburg, Russia
12Clinical Hospital №31, Saint-Petersburg, Russia
13Regional Clinical Hospital, Saint-Petersburg, Russia
14Regional Clinical Hospital, Samara, Russia
15Saransk Clinical Hospital, Saransk, Russia
16Ekaterinburg Clinical Hospital, Ekaterinburg, Russia
17Tambov's Regional Hospital, Tambov, Russia
18Clinical Oncology Hospital, Volgograd, Russia
19Yaroslavl Regional Hospital, Yaroslavl, Russia
20Ryazan Clinical Hospital, Ryazan, Russia
21Regional Clinical Hospital, Belgorod, Russia

Ryan D. Cassaday, MD1,2,3, Philip A. Stevenson4*, Brent L. Wood, MD, PhD3,5, Pamela S. Becker, MD, PhD1,2,3, Paul C. Hendrie, MD, PhD2,3*, Brenda M. Sandmaier, MD1,3,6, Jerald P. Radich1,3,6 and Andrei R. Shustov, MD1,2,3

1Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA
2Division of Hematology, University of Washington, Seattle, WA
3Seattle Cancer Care Alliance, Seattle, WA
4Clinical Statistics Division, Fred Hutchinson Cancer Research Center, Seattle, WA
5Department of Laboratory Medicine/Division of Hematopathology, University of Washington, Seattle, WA
6Division of Medical Oncology, University of Washington, Seattle, WA

Jessica C. Hochberg, MD1*, Javier Oesterheld, MD2*, Olga Miitano, PharmD1*, Lauren Harrison, RN, MSN1* and Mitchell S. Cairo, MD1,3,4,5,6

1Pediatrics, New York Medical College, Valhalla, NY
2Pediatric Blood and Marrow Transplantation, Levine Children's Hospital, Charlotte, NC
3Pathology, New York Medical College, Valhalla, NY
4Cell Biology & Anatomy, New York Medical College, Valhalla, NY
5Microbiology & Immunology, New York Medical College, Valhalla, NY
6Medicine, New York Medical College, Valhalla, NY

Ryota Imanaka, MD1*, Taiichi Kyo, MD1, Kayo Toishigawa, MD2*, Tetsuro Ochi, MD1*, Takeshi Okatani, MD1*, Kouhei Kyo, MD1*, Mitsuhiro Itagaki, MD1*, Hisao Nagoshi, MD3*, Yuta Katayama, MD, PhD1*, Koji Iwato, MD4* and Hideki Asaoku, MD5*

1Internal Medicine, Hiroshima Red Cross Hospital & Atomic-bomb Survivors Hospital, Hiroshima, Japan
2Internal Medicine, Hiroshima Red Cross Hospital, Hiroshima, Japan
3Division of Hematology and Oncology, Kyoto Prefectural University of Medicine, Kyoto, Japan
4Department of Transfusion, Hiroshima Red Cross Hospital, Hiroshima, Japan
5Department of Laboratory, Hiroshima Red Cross Hospital, Hiroshima, Japan

Gertjan J.L. Kaspers, MD, PhD1, Denise Niewerth, PhD1*, Bram Wilhelm, PharmD2*, Satianand Ramnarain, MSc3*, Hans Berkhof, PhD4*, Valerie De Haas, MD, PhD5, Ron A.A. Mathôt, PharmD, PhD6*, Andishe Attarbaschi, MD7*, Andre Baruchel, MD8, Eveline S. de Bont9, Franca Fagioli, MD10*, Claudia Rossig, MD11, Thomas Klingebiel, MD12, Barbara De Moerloose, MD, PhD13*, Brigitte Nelken, MD14*, Giuseppe Palumbo, MD15*, Dirk Reinhardt, MD16, Pierre Simon Rohrlich, MD17*, Pauline Simon, MD18*, Arend Stackelberg, MD19* and C. Michel Zwaan, MD, PhD20

1Department of Pediatric Oncology/Hematology, VU University Medical Center, Amsterdam, Netherlands
2Laboratory of Pharmacology and Pharmacy, VU University Medical Center, Amsterdam, Netherlands
3Pediatric Oncology, Erasmus MC, Rotterdam, Netherlands
4Department of Epidemiology & Biostatistics, VU University Medical Center, Amsterdam, Netherlands
5Dutch Childhood Oncology Group, The Hague, Netherlands
6Clinical Pharmacology, Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands
7Children's Cancer Research Institute and St. Anna Kinderspital, Vienna, Austria
8Dept. of Pediatric Hematology, Hopital Saint Louis, Paris, France
9Department of Pediatric Oncology/Hematology, Beatrix Children’s Hospital, University Medical Center Groningen, University of Groningen, Groningen, Netherlands
10Università degli Studi di Torino, Turin, Italy
11Pediatric Hematology and Oncology, University Hospital Münster, Münster, Germany
12Department of Pediatrics, University Hospital Frankfurt, Frankfurt am Main, Germany
13Department of Pediatrics, Ghent University, Ghent, Belgium
14Pediatric Hematology, Hospital Jeanne de Flandre, Lille, France
15Ospedale Pediatrico Bambino Gesù, Rome, Italy
16AML-BFM Study Group, Pediatric Hematology/Oncology, University Children’s Hospital Essen, Essen, Germany
17Hematology-Pediatry, CHU L'Archet, Nice, France
18Pediatric Oncology, University Hospital of Besancon, Besancon, France
19Department of Pediatric Oncology/Hematology, Charité Universitätsmedizin, Berlin, Germany
20Pediatric Hematology/Oncology, DCOG, Den Haag, Erasmus MC - Sophia Children's Hospital, Den Haag, Rotterdam, Netherlands

Karen R. Rabin, MD, PhD1, Johann Hitzler, MD, FRCP (C), FAAP2, Vilmarie Rodriguez, MD3, Reuven Schore, MD4, Anne Angiolillo, MD4*, Michael J. Burke, MD5,6, Wanda Salzer, MD7, Kelly Maloney, MD8, Xiaomin Lu, Ph.D.9*, Meenakshi Devidas, PhD10, Mignon L. Loh, MD11, Elizabeth Raetz, MD12 and Stephen P Hunger, MD13

1Pediatrics, Hematology/Oncology, Baylor College of Medicine, Houston, TX
2Division of Haematology/Oncology, Department of Pediatrics, The Hospital for Sick Children, Toronto, ON, Canada
3Division of Pediatric Hematology and Oncology, Mayo Clinic, Rochester, MN
4Children's National Medical Center, Washington, DC
5Division of Hematology/Oncology/Bone Marrow Transplantation, Medical College of Wisconsin, Milwaukee, WI
6Children's Hospital of Wisconsin, Milwaukee, WI
7U.S. Army Medical Research and Materiel Command, Fort Detrick, MD
8The Childrens' Hospital Colorado, Aurora, CO
9Department of Biostatistics, University of Florida, Gainesville, FL
10Department of Biostatistics, Colleges of Medicine, Public Health & Health Profession, University of Florida, Gainesville, FL
11Department of Pediatrics, Benioff Children’s Hospital, University of California at San Francisco, San Francisco, CA
12Department of Pediatrics, Huntsman Cancer Institute and Primary Children's Hospital, University of Utah, Salt Lake City, UT
13Department of Pediatrics, Children’s Hospital of Philadelphia and the University of Pennsylvania Perelman School of Medicine, Philadelphia, PA

Guillermo Montalban-Bravo, MD1*, Hagop M. Kantarjian, MD2, Punit L Jain, MD1*, Guillermo Garcia-Manero, MD3, Farhad Ravandi, MD2, Jorge E. Cortes, MD3, Naval Daver, MD4, Koichi Takahashi, MD2, Nitin Jain, MD2, Srdan Verstovsek, MD2, Tapan Kadia, MD2, Sherry Pierce, BSN, BA2* and Elias Jabbour2

1Department of Leukemia, M D Anderson Cancer Center, Houston, TX
2Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
3Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX
4Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, Houston, TX

Guillermo Montalban-Bravo, MD1*, Hagop M. Kantarjian, MD2, Jorge E. Cortes, MD2, Farhad Ravandi, MD2, Guillermo Garcia-Manero, MD2, Jain Punit, MD3*, Naveen Pemmaraju, MD2, Gautam Borthakur, MD2, Tapan Kadia, MD2, Marina Konopleva, MD, PhD4, Sherry Pierce, BSN, BA2*, Susan O'Brien, MD5 and Elias Jabbour2

1Department of Leukemia, M D Anderson Cancer Center, Houston, TX
2Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
3Department of Leukemia, MD Anderson Cancer Center, Houston, TX
4Section of Molecular Hematology and Therapy, Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
5University of California - Irvine, Orange, CA

*signifies non-member of ASH